commercialisation

R&D

Reimagining biopharma: How AI is reshaping discovery, develo...

No longer confined to experimental pilots, AI is becoming a catalyst for change across the entire biopharma value chain - but there are challenges.

R&D

A man stood on a rock looking towards the horizon

A New Framework to Engineer Breakthrough Value for Medicines

A new white paper from Lumanity – ‘A New Framework to Engineer Breakthrough Value for Medicines: Value Inflection Points Across the Development Path’.

Partner Content

Citius Oncology Signs Exclusive Commercialization Agreement ...

Citius Oncology Signs Exclusive Commercialization Agreement with EVERSANA to Support Planned Q4 2025 Launch of LYMPHIR™

Digital

Agents of change: AI’s role in the future of pharma commerci...

Sales & Marketing

5 Things to watch at Fierce Pharma Week 2025: What every pha...

Fierce Pharma Week 2025, 8th to 11th September 2025 in Philadelphia marks a historic shift in pharmaceutical industry events.

Oncology

Interview at ASCO 2025 with Christine Roth

Reimagining biopharma: How AI is reshaping discovery, develo...

A New Framework to Engineer Breakthrough Value for Medicines

Citius Oncology Signs Exclusive Commercialization Agreement ...

Agents of change: AI’s role in the future of pharma commerci...

5 Things to watch at Fierce Pharma Week 2025: What every pha...

From prostate cancer to breast cancer: In conversation with ...

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

commercialisation

Editor's Picks